Our vision is to help increase cancer survival rate by 30% by 2030 and co-create the future of fighting cancer as well as other serious chronic diseases.

We are first ever European based cutting-edge medical DeepTech connecting molecular biology with novel photonics technologies, chemistry & biomedical engineering.
We create solutions that can revolutionize healthcare worldwide, incl. the first ever In Vivo Photonics Immunoassays platform - inPROBE® technology.

We are merging competences of scientists and experts from many different scientific and business fields.

SDS Optic Inc.

Org chart

Teams

Offices